Dr. Lal PathLabs (DLPL) has become the first laboratory in the country to adopt a deep learning-based AI module to detect lymph node metastasis, including micrometastasis, in cancer cases. This cutting edge technology, validated in collaboration with Qritive, was showcased at USCAP 2025 one of the world's leading pathology conferences.
Accurate identification of cancer spread to lymph nodes is vital in determining the stage and treatment path for patients. If the spread of cancer to the lymph nodes is left undetected, it can allow the disease to progress to later stages, increasing the risk of metastasis to distant organs and significantly reducing survival rates. Therefore, the identification of occult metastases in patients with early-stage cancer could have a substantial clinical impact on treatment planning and optimal therapy for patients with cancer.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
